78 related articles for article (PubMed ID: 20232438)
21. Etomoxir: a new approach to treatment of chronic heart failure.
Bristow M
Lancet; 2000 Nov; 356(9242):1621-2. PubMed ID: 11089814
[No Abstract] [Full Text] [Related]
22. Inhibitors of fatty acid oxidation.
Schulz H
Life Sci; 1987 Apr; 40(15):1443-9. PubMed ID: 3550347
[TBL] [Abstract][Full Text] [Related]
23. [Drug therapy in adult-onset diabetes].
Groop L; Uusitupa M
Duodecim; 1990; 106(9):759-65. PubMed ID: 1670368
[No Abstract] [Full Text] [Related]
24. Indole-2-carboxamide inhibitors of human liver glycogen phosphorylase.
Hoover DJ; Lefkowitz-Snow S; Burgess-Henry JL; Martin WH; Armento SJ; Stock IA; McPherson RK; Genereux PE; Gibbs EM; Treadway JL
J Med Chem; 1998 Jul; 41(16):2934-8. PubMed ID: 9685232
[No Abstract] [Full Text] [Related]
25. Accumulation and excretion of long-chain acylcarnitine by rat hearts; studies with aminocarnitine.
Hülsmann WC; Schneijdenberg CT; Verkleij AJ
Biochim Biophys Acta; 1991 Nov; 1097(4):263-9. PubMed ID: 1742330
[TBL] [Abstract][Full Text] [Related]
26. A characteristic Glu17 residue of pig carnitine palmitoyltransferase 1 is responsible for the low Km for carnitine and the low sensitivity to malonyl-CoA inhibition of the enzyme.
Relat J; Pujol-Vidal M; Haro D; Marrero PF
FEBS J; 2009 Jan; 276(1):210-8. PubMed ID: 19049515
[TBL] [Abstract][Full Text] [Related]
27. [The action of carnitine-series preparations in experimental alloxan diabetes mellitus].
Kim EK; Trevisani C; Trevisani M
Eksp Klin Farmakol; 1992; 55(4):35-6. PubMed ID: 1458184
[TBL] [Abstract][Full Text] [Related]
28. Carnitine analogues and carnitine palmitoyltransferases.
Murthy MS; Ramsay RR; Pande SV
Biochem Soc Trans; 1990 Aug; 18(4):604-5. PubMed ID: 2276460
[No Abstract] [Full Text] [Related]
29. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
[TBL] [Abstract][Full Text] [Related]
30. Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitors.
Anderson RC; Balestra M; Bell PA; Deems RO; Fillers WS; Foley JE; Fraser JD; Mann WR; Rudin M; Villhauer EB
J Med Chem; 1995 Sep; 38(18):3448-50. PubMed ID: 7658430
[No Abstract] [Full Text] [Related]
31. Evolutionary chemistry approach toward finding novel inhibitors of the type 2 diabetes target glucose-6-phosphate translocase.
Bräuer S; Almstetter M; Antuch W; Behnke D; Taube R; Furer P; Hess S
J Comb Chem; 2005; 7(2):218-26. PubMed ID: 15762749
[TBL] [Abstract][Full Text] [Related]
32. C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.
Mera P; Bentebibel A; López-Viñas E; Cordente AG; Gurunathan C; Sebastián D; Vázquez I; Herrero L; Ariza X; Gómez-Puertas P; Asins G; Serra D; García J; Hegardt FG
Biochem Pharmacol; 2009 Mar; 77(6):1084-95. PubMed ID: 19094968
[TBL] [Abstract][Full Text] [Related]
33. A monotopic membrane protein goes solo.
Mattevi A
Structure; 2006 Apr; 14(4):628-9. PubMed ID: 16615901
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.
Onda K; Suzuki T; Shiraki R; Yonetoku Y; Negoro K; Momose K; Katayama N; Orita M; Yamaguchi T; Ohta M; Tsukamoto S
Bioorg Med Chem; 2008 May; 16(10):5452-64. PubMed ID: 18434170
[TBL] [Abstract][Full Text] [Related]
35. A biomimetic heteroditopic receptor for zwitterions in protic media.
Cornut D; Moerkerke S; Wouters J; Bruylants G; Jabin I
Chem Asian J; 2015 Feb; 10(2):440-6. PubMed ID: 25394389
[TBL] [Abstract][Full Text] [Related]
36. Treating type 2 diabetes: a growing number of options.
Neumiller JJ; To S
Diabetes Self Manag; 2011; 28(4):38, 40-2. PubMed ID: 21848053
[No Abstract] [Full Text] [Related]
37. Synthesis of carnitine precursors and related compounds.
Rebouche CJ
Methods Enzymol; 1986; 123():290-7. PubMed ID: 3084916
[No Abstract] [Full Text] [Related]
38. Stereoselective synthesis of a conformationally defined cyclohexyl carnitine analogue that binds CPT-1 with high affinity.
Hutchison TL; Saeed A; Wolkowicz PE; McMillin JB; Brouillette WJ
Bioorg Med Chem; 1999 Aug; 7(8):1505-11. PubMed ID: 10482442
[TBL] [Abstract][Full Text] [Related]
39. A reversible carnitine palmitoyltransferase (CPT1) inhibitor offsets the proliferation of chronic lymphocytic leukemia cells.
Gugiatti E; Tenca C; Ravera S; Fabbi M; Ghiotto F; Mazzarello AN; Bagnara D; Reverberi D; Zarcone D; Cutrona G; Ibatici A; Ciccone E; Darzynkiewicz Z; Fais F; Bruno S
Haematologica; 2018 Nov; 103(11):e531-e536. PubMed ID: 29930162
[No Abstract] [Full Text] [Related]
40. Inhibition of carnitine palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice.
Haynie KR; Vandanmagsar B; Wicks SE; Zhang J; Mynatt RL
Diabetes Obes Metab; 2014 Aug; 16(8):757-60. PubMed ID: 24330405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
